#news #biotech UniQure’s hemophilia B gene therapy clears another clinical test

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: UniQure’s hemophilia B gene therapy clears another clinical test .UniQure has posted 12-week data on its hemophilia B gene therapy. The update suggests FIX activity increases seen at six weeks are sustainable, giving uniQure a boost as it races Spark Therapeutics to market. 

from FierceBiotech: Biotech http://bit.ly/2TIeNjK